Pricing Log in Create free account

Coya Therapeutics, Inc. (COYA) vs Nordicus Partners Corporation (NORD)

Coya Therapeutics, Inc. and Nordicus Partners Corporation are both Biotechnology companies. Coya Therapeutics, Inc. and Nordicus Partners Corporation are of similar size ($65.9M and $63.2M). Coya Therapeutics, Inc. grew revenue faster over the last twelve months: 108.4% against −71.7%. Nordicus Partners Corporation has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (−4.43% vs −15,230.9%). Across the 16 metrics below, Nordicus Partners Corporation leads on 11 and Coya Therapeutics, Inc. on 5.

Valuation

Metric COYA NORD Biotechnology median
P/E n/m n/m 10.26
P/S 8.25 81.31 9.18
P/B 1.53 1.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 4.48 83.80 8.98
Earnings yield (37.94%) (8.24%) (34.89%)
Free cash flow yield (26.87%) (6.25%) (24.52%)

Profitability

Metric COYA NORD Biotechnology median
Gross margin 100.00% 70.18% 65.16%
Operating margin (288.70%) 0.00% 0.00%
Net margin (270.22%) 0.00% 0.00%
Free cash flow margin (221.64%) 0.00% 0.00%
Return on equity (60.54%) (8.06%) (50.12%)
Return on assets (53.66%) (6.80%) (45.60%)
Return on invested capital (15,230.92%) (4.43%) 0.00%

Growth

Metric COYA NORD Biotechnology median
Revenue growth (TTM) 108.35% (71.68%) 6.26%
EPS growth (last fiscal year) (29.59%) 30.58% 29.88%
Revenue growth, 5-year CAGR — (71.31%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA NORD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 0.18 4.89
Net debt to EBITDA 2.08 0.00 1.01

Dividend

Metric COYA NORD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COYA NORD Biotechnology median
Market cap 65.92m 63.19m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack